Xeljanz XR 11 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FK4PB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,448
Award facts
- Contract value 100% obligated
- $28,448.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $28,448 delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for XELJANZ XR 11 mg tablets (30-count units) under firm fixed-price terms. Ultimate completion date is March 9, 2026. Place of performance is Conshohocken, PA. The order carries no set-aside.
Quick answers
Who was awarded contract SPE2DR26FK4PB?
SPE2DR26FK4PB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 6, 2026.
How much is contract SPE2DR26FK4PB worth?
The government has obligated $28,448 on SPE2DR26FK4PB.
Is contract SPE2DR26FK4PB an order under another contract?
Yes. SPE2DR26FK4PB is a delivery order under SPE2DR25D3019, an indefinite delivery contract.
Was contract SPE2DR26FK4PB competed?
The extent of competition for SPE2DR26FK4PB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award